If this box remains here for more than 30 seconds, click this link to try again.
Products & Services »
Best Practice Database
Medical Affairs » Medical Science Liaison
Download FREE Excerpt
3 Info Graphics
27 Data Graphics
Single User: Authorizes use by the person who places the order or for whom the order was placed.
Sitewide: Authorizes use of the report for a geographic site. All people at site can view the report for a year and copies can be printed.
Corporate: Authorizes use for the entire company for a year and copies can be printed. No limitations for usage inside the company.
Investment in rare disease therapeutics has exponentially increased since implementation of government incentives for developing orphan drug treatment paradigms. Pharma firms pursuing these therapeutic areas are likely to have little competition for their treatments, but also little knowledge of the intricacies of the patient communities and the health care providers that serve them.
For these reasons, strong field medical teams are critical for successful rare disease therapeutics.
Best Practices, LLC undertook this benchmarking research to characterize what reporting structures, success factors, activities, and tools drive great rare disease field medical teams.
Segmentation used in the study:Total Benchmark Class (15 respondents); US Only (n=8) and Excluding-US (n=5)
For this study, Best Practices, LLC engaged 15 leaders from 12 companies through a benchmarking survey instrument.